Amina M. Bagher

2.1k total citations · 2 hit papers
44 papers, 1.6k citations indexed

About

Amina M. Bagher is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Amina M. Bagher has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in Amina M. Bagher's work include Cannabis and Cannabinoid Research (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Amina M. Bagher is often cited by papers focused on Cannabis and Cannabinoid Research (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Amina M. Bagher collaborates with scholars based in Saudi Arabia, Canada and Egypt. Amina M. Bagher's co-authors include Eileen M. Denovan‐Wright, Robert B. Laprairie, Michael E. Kelly, Denis J. Dupré, Basma G. Eid, Mohammed S. Almuhayawi, Shaimaa M. Badr-Eldin, Badrah S. Alghamdi, Steve Harakeh and Samar A. Alghamdi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Amina M. Bagher

38 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol is a negative allosteric modulator of the cannabinoid CB ₁ receptor

2015 790 citations Robert B. Laprairie, Amina M. Bagher et al. British Journal of Pharmacology profile →
Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study

2021 167 citations Nagla A. El‐Shitany, Steve Harakeh et al. International Journal of General Medicine profile →

Peers

Countries citing papers authored by Amina M. Bagher

Since Specialization

Citations

This map shows the geographic impact of Amina M. Bagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina M. Bagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina M. Bagher more than expected).

Fields of papers citing papers by Amina M. Bagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina M. Bagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina M. Bagher. The network helps show where Amina M. Bagher may publish in the future.

Co-authorship network of co-authors of Amina M. Bagher

This figure shows the co-authorship network connecting the top 25 collaborators of Amina M. Bagher. A scholar is included among the top collaborators of Amina M. Bagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina M. Bagher. Amina M. Bagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Topical β-Caryophyllene for Dermatologic Disorders: Mechanisms, Human Evidence, and Clinical Translation 2025 ·Pharmaceuticals ·Amina M. Bagher	0
2	Piceatannol protects against cisplatin-induced ovarian toxicity in rats via modulation of PTEN/PI3 K/AKT axis 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), (unknown), Amina M. Bagher, Rasheed A. Shaik, Ashraf B. Abdel‐Naim, Basma G. Eid	0
3	Luteolin modulates the TGFB1/PI3K/PTEN axis in hormone-induced uterine leiomyomas: Insights from a rat model 2025 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Ashraf B. Abdel‐Naim, Basma G. Eid, Rasheed A. Shaik, Amina M. Bagher	0
4	Berberine alleviates chlorpyrifos-induced nephrotoxicity in rats via modulation of Nrf2/HO-1 axis 2024 ·Heliyon ·(unknown), Emad H. M. Hassanein, Amina M. Bagher, (unknown), Zaenah Zuhair Alamri, Mardi M. Algandaby, Mohamed M. Abdel‐Daim, Ashraf B. Abdel‐Naim	4
5	Parthenolide Phytosomes Attenuated Gentamicin-Induced Nephrotoxicity in Rats via Activation of Sirt-1, Nrf2, OH-1, and NQO1 Axis 2023 ·Molecules ·(unknown), (unknown), (unknown), Rasheed A. Shaik, Amina M. Bagher	17
6	The effect of virtual reality distraction on anxiety level during dental treatment among anxious pediatric patients: a randomized clinical trial 2023 ·Journal of Clinical Pediatric Dentistry ·Sara M. Bagher, Osama M. Felemban, (unknown), (unknown), (unknown), Amina M. Bagher	11
7	Lycopene attenuates chlorpyrifos-induced hepatotoxicity in rats via activation of Nrf2/HO-1 axis 2023 ·Ecotoxicology and Environmental Safety ·Ashraf B. Abdel‐Naim, Emad H. M. Hassanein, (unknown), Amina M. Bagher, (unknown), Mardi M. Algandaby, (unknown), Lotfi Aleya, Mohamed M. Abdel‐Daim	10
8	Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats 2023 ·SHILAP Revista de lepidopterología ·Basma G. Eid, Thikryat Neamatallah, (unknown), Amina M. Bagher, Abdulmohsin J. Alamoudi, Hibah M. Aldawsari, Abeer Hanafy, (unknown), Hany M. El‐Bassossy, Ashraf B. Abdel‐Naim, Kiran Vemuri, Alexandros Makriyannis	0
9	Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population 2023 ·Journal of Applied Biomedicine ·Amina M. Bagher, (unknown)	1
10	Garcinone E Mitigates Oxidative Inflammatory Response and Protects against Experimental Autoimmune Hepatitis via Modulation of Nrf2/HO-1, NF-κB and TNF-α/JNK Axis 2022 ·Nutrients ·Gamal A. Mohamed, Sabrin R. M. Ibrahim, (unknown), (unknown), Amina M. Bagher, Hossam M. Abdallah, Wael M. Elsaed, Dina S. El‐Agamy	8
11	The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study 2022 ·International Journal of General Medicine ·Nagla A. El‐Shitany, Amina M. Bagher, (unknown), Basma G. Eid, Haifa Almukadi, Shaimaa M. Badr-Eldin, Manal El‐Hamamsy, Zuhair M. Mohammedsaleh, Fayez M. Saleh, Mohammed S. Almuhayawi, Samar A. Alghamdi, (unknown), Soad Shaker Ali, Steve Harakeh, Badrah S. Alghamdi	11
12	Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats 2021 ·GeroScience ·A. P. Young, (unknown), Amina M. Bagher, Eileen M. Denovan‐Wright, Susan E. Howlett, Michael E. Kelly	10
13	Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study breakdown → 2021 ·International Journal of General Medicine ·Nagla A. El‐Shitany, Steve Harakeh, Shaimaa M. Badr-Eldin, Amina M. Bagher, Basma G. Eid, Haifa Almukadi, Badrah S. Alghamdi, Ahlam A. Alahmadi, (unknown), (unknown), Samar A. Alghamdi, Hailah M. Almohaimeed, Zuhair M. Mohammedsaleh, Turki M. Al-Shaikh, Mohammed S. Almuhayawi, Soad Shaker Ali, Manal El‐Hamamsy	167
14	Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia 2020 ·Saudi Pharmaceutical Journal ·Amina M. Bagher, Thikryat Neamatallah, (unknown), (unknown), (unknown), (unknown), Khlood Baghlaf, Sara M. Bagher	17
15	Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model 2019 ·Neuropharmacology ·Robert B. Laprairie, Amina M. Bagher, Jillian L. Rourke, (unknown), Elizabeth A. Cairns, Michael E. Kelly, Christopher J. Sinal, (unknown), Ganesh A. Thakur, Eileen M. Denovan‐Wright	44
16	Bidirectional allosteric interactions between cannabinoid receptor 1 (CB 1 ) and dopamine receptor 2 long (D 2L ) heterotetramers 2017 ·European Journal of Pharmacology ·Amina M. Bagher, Robert B. Laprairie, James Thomas Toguri, Michael E. Kelly, Eileen M. Denovan‐Wright	32
17	Cannabinoid receptor ligand bias: implications in the central nervous system 2016 ·Current Opinion in Pharmacology ·Robert B. Laprairie, Amina M. Bagher, Eileen M. Denovan‐Wright	55
18	Cannabidiol is a negative allosteric modulator of the cannabinoid CB ₁ receptor breakdown → 2015 ·British Journal of Pharmacology ·Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, Eileen M. Denovan‐Wright	790
19	Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature 2014 ·European Journal of Pharmacology ·(unknown), (unknown), Alex Straiker, (unknown), Susan E. Howlett, Amina M. Bagher, Eileen M. Denovan‐Wright, Dao‐Yi Yu, Michael E. Kelly	52
20	Co-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes 2013 ·European Journal of Pharmacology ·Amina M. Bagher, Robert B. Laprairie, Michael E. Kelly, Eileen M. Denovan‐Wright	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact